Product Information
APREPITANT 125 MG CAPSULE is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $115.3368 per EA under NDC 13668059386. Its NADAC has been published 80 times since Dec 18, 2024.
Strength
125 mg/1
Manufacturer
Torrent Pharmaceuticals LimitedNDC
13668059386
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
APREPITANTApproval Type
Generic (ANDA)
FDA Application
ANDA211835On Market Since
10/21/2020
Pharmacological Classes
Price Statistics
The NADAC for APREPITANT 125 MG CAPSULE has been published 80 times since Dec 18, 2024, and over the history we have for it it has declined 36.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $115.3368 per EA |
|---|---|
| All-time high | $199.2198 (Sep 10, 2025) |
| All-time low | $115.3368 (Jun 17, 2026) |
| 52-week high | $199.2198 |
| 52-week low | $115.3368 |
| Median price | $172.7479 |
| Average price | $164.9959 |
| Largest weekly change | -11.9% (Jan 21, 2026) |
| Weeks tracked | 80 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the APREPITANT market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of APREPITANT 125 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for APREPITANT 125 MG CAPSULE, manufactured by Torrent Pharmaceuticals Limited, is $115.3368 per EA (NDC 13668059386), effective Jun 24, 2026.
How has the price of APREPITANT 125 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for APREPITANT 125 MG CAPSULE has declined 36.7%. It has been tracked across 80 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for APREPITANT 125 MG CAPSULE?
Since Dec 18, 2024, the NADAC for APREPITANT 125 MG CAPSULE has ranged from a low of $115.3368 (Jun 17, 2026) to a high of $199.2198 (Sep 10, 2025), with a median of $172.7479 per EA.
Are there cheaper alternatives to APREPITANT 125 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of APREPITANT 125 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures APREPITANT 125 MG CAPSULE?
APREPITANT 125 MG CAPSULE (NDC 13668059386) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification